Skin Depigmentation After Particulate Steroid Injection for de Quervain's Tenosynovitis.

Pain medicine case reports Pub Date : 2025-04-01
Simon Yang, Vinh Nguyen, Ratan K Banik
{"title":"Skin Depigmentation After Particulate Steroid Injection for de Quervain's Tenosynovitis.","authors":"Simon Yang, Vinh Nguyen, Ratan K Banik","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Corticosteroid injections are an effective treatment for several medical conditions, including de Quervain's tenosynovitis. Depigmentation of the skin after steroid injection is rarely reported.</p><p><strong>Case report: </strong>We present a case of a 43-year-old man who has no significant past medical history and came to us with an 8-week history of left wrist pain consistent with de Quervain's tenosynovitis. He underwent injections of triamcinolone and bupivacaine into the tendon sheath of the extensor pollicis brevis and abductor pollicis longus. Shortly after 3-5 days posttreatment, he had 100% pain relief, which continued for 12 months. However, one week after injection, he developed depigmentation at the injection site, measuring 2 cm x 3 cm. Depigmentation spontaneously resolved after 9 months.</p><p><strong>Discussion: </strong>The exact etiology of steroid-induced depigmentation is unknown, but it can have a profound impact on the patient. Interventional pain physicians should counsel patients about this adverse outcome and be aware of how to minimize its likelihood.</p>","PeriodicalId":520525,"journal":{"name":"Pain medicine case reports","volume":"9 2","pages":"143-146"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain medicine case reports","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Corticosteroid injections are an effective treatment for several medical conditions, including de Quervain's tenosynovitis. Depigmentation of the skin after steroid injection is rarely reported.

Case report: We present a case of a 43-year-old man who has no significant past medical history and came to us with an 8-week history of left wrist pain consistent with de Quervain's tenosynovitis. He underwent injections of triamcinolone and bupivacaine into the tendon sheath of the extensor pollicis brevis and abductor pollicis longus. Shortly after 3-5 days posttreatment, he had 100% pain relief, which continued for 12 months. However, one week after injection, he developed depigmentation at the injection site, measuring 2 cm x 3 cm. Depigmentation spontaneously resolved after 9 months.

Discussion: The exact etiology of steroid-induced depigmentation is unknown, but it can have a profound impact on the patient. Interventional pain physicians should counsel patients about this adverse outcome and be aware of how to minimize its likelihood.

颗粒类固醇注射治疗de Quervain腱鞘炎后皮肤色素脱失。
背景:皮质类固醇注射是几种疾病的有效治疗方法,包括de Quervain氏腱鞘炎。类固醇注射后皮肤色素脱失很少有报道。病例报告:我们报告了一个43岁的男性病例,他没有明显的既往病史,8周的左手腕疼痛史与de Quervain的腱鞘炎一致。在拇短伸肌和拇长外展肌肌腱鞘内注射曲安奈德和布比卡因。治疗后3-5天,患者疼痛100%缓解,持续12个月。然而,注射后一周,他在注射部位出现了2厘米× 3厘米的色素沉着。9个月后色素消退。讨论:类固醇诱发的色素脱色的确切病因尚不清楚,但它对患者有深远的影响。介入性疼痛医生应告知患者这种不良后果,并了解如何将其可能性降到最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信